Skip Navigation

Anita Roberts Lecture - Advancing the Development of Effective Therapies for Children and Adults with Rare Tumors

Loading video...

390 Views

Air date: Thursday, November 3, 2022, 11:00:00 AM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 390 (313 Live, 77 On-demand)
Category: Anita B. Roberts - Distinguished Women Scientists
Runtime: 01:12:08
Description: Anita Roberts Lecture 2022

The “Distinguished Women Scientists at NIH” lecture series highlights the outstanding research achievements of woman scientists in the NIH Intramural Research Program. This seminar is dedicated to Dr. Anita Roberts and honors her role as an exceptional mentor and scientist.

Dr. Widemann is the Chief of the Pediatric Oncology Branch at NCI where she oversees basic, translational, and clinical research programs for children and young adults with hematologic and solid malignancies. Her research has been focused on drug development and early clinical trials for children with refractory solid tumors or genetic tumor predisposition syndromes, in particular neurofibromatosis type 1 (NF1). Her findings resulted in the first approved medical therapy for children with NF1.
NLM Title: Advancing the development of effective therapies for children and adults with rare tumors / Brigitte Widemann.
Author: Widemann, Brigitte.
NIH Women Scientist Advisors Committee,
Publisher:
Abstract: (CIT): Anita Roberts Lecture 2022 The "Distinguished Women Scientists at NIH" lecture series highlights the outstanding research achievements of woman scientists in the NIH Intramural Research Program. This seminar is dedicated to Dr. Anita Roberts and honors her role as an exceptional mentor and scientist. Dr. Widemann is the Chief of the Pediatric Oncology Branch at NCI where she oversees basic, translational, and clinical research programs for children and young adults with hematologic and solid malignancies. Her research has been focused on drug development and early clinical trials for children with refractory solid tumors or genetic tumor predisposition syndromes, in particular neurofibromatosis type 1 (NF1). Her findings resulted in the first approved medical therapy for children with NF1.
Subjects: Neoplasms--therapy
Rare Diseases--therapy
Therapies, Investigational
Publication Types: Lecture
Webcast
 
NLM Classification: QZ 266
NLM ID: 9918573275406676
CIT Live ID: 45832
Permanent link: https://videocast.nih.gov/watch=45832

Related Videos...

Click Here to Play Video.
07:44:33
NCI - Board of Scientific Advisors (Day 1)
[NCI Board of Scientific Advisors]
11/14/2002
Click Here to Play Video.
05:38:58
Women's Health Interdisciplinary Research Symposium (Day 2)
[Women's Health]
10/5/2004
Click Here to Play Video.
07:31:22
National Cancer Advisory Board (NCAB) June 2006
[National Cancer Advisory Board]
6/14/2006
Click Here to Play Video.
07:59:01
NCI Board of Scientific Advisors - June 2006 (Day 1)
[NCI Board of Scientific Advisors]
6/29/2006
Click Here to Play Video.
08:54:44
NCI Board of Scientific Advisors - November 2007 (Day 1)
[NCI Board of Scientific Advisors]
11/15/2007
Click Here to Play Video.
06:26:01
Genes, Environment and Health Initiative: Translating Whole Genome Association Data into Clinical Practice (Day 1)
[Conferences]
3/10/2008
Click Here to Play Video.
06:38:35
Nanotechnology at NIH: Basic Concepts, Current Research, and Medical Applications
[Conferences]
4/7/2009
Click Here to Play Video.
06:43:50
Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) - Day 1
[Advisory Boards and Councils]
10/29/2009
Click Here to Play Video.
06:22:58
20th Anniversary of the Office of research on women's Health
[Women's Health]
9/27/2010
Click Here to Play Video.
03:00:45
National Advisory Child Health and Human Development Council - June 2023 (Day 2)
[National Institute of Child Health and Human Development ]
6/7/2023